StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)

Close on Nov 18, 2026Market cap $195.97MP/E –Yield –

Precision BioSciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Precision BioSciences's pe ratio was 6.5× on Apr 30, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20256.5×−57.0
2024Dec 31, 202463.5×–

More Precision BioSciences figures

See a number that looks wrong?